10.17
전일 마감가:
$10.00
열려 있는:
$10.02
하루 거래량:
1.06M
Relative Volume:
1.50
시가총액:
$602.27M
수익:
$1.10B
순이익/손실:
$83.60M
주가수익비율:
7.1119
EPS:
1.43
순현금흐름:
$132.30M
1주 성능:
-6.40%
1개월 성능:
-19.67%
6개월 성능:
-27.04%
1년 성능:
-37.03%
Embecta Corp Stock (EMBC) Company Profile
명칭
Embecta Corp
전화
(862) 401-0000
주소
1209 ORANGE STREET, WILMINGTON
Compare EMBC vs ISRG, BDX, ALC, MDLN, RMD
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
|
EMBC
Embecta Corp
|
10.17 | 592.20M | 1.10B | 83.60M | 132.30M | 1.43 |
|
ISRG
Intuitive Surgical Inc
|
485.84 | 169.97B | 10.06B | 2.88B | 2.49B | 7.876 |
|
BDX
Becton Dickinson Co
|
175.89 | 50.58B | 21.92B | 1.76B | 2.63B | 6.1223 |
|
ALC
Alcon Inc
|
79.20 | 38.58B | 10.19B | 1.05B | 1.38B | 2.1044 |
|
MDLN
Medline Inc
|
44.55 | 37.11B | 27.43B | 1.27B | 1.01B | 1.5829 |
|
RMD
Resmed Inc
|
252.55 | 35.80B | 5.40B | 1.49B | 1.78B | 10.12 |
Embecta Corp Stock (EMBC) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-04-10 | 개시 | Mizuho | Neutral |
| 2024-12-02 | 업그레이드 | Morgan Stanley | Underweight → Equal-Weight |
| 2024-11-27 | 업그레이드 | BTIG Research | Neutral → Buy |
| 2023-10-20 | 개시 | Wolfe Research | Peer Perform |
| 2023-01-06 | 다운그레이드 | Morgan Stanley | Equal-Weight → Underweight |
| 2022-09-08 | 개시 | BTIG Research | Neutral |
| 2022-08-01 | 개시 | Morgan Stanley | Equal-Weight |
| 2022-06-21 | 개시 | BofA Securities | Underperform |
모두보기
Embecta Corp 주식(EMBC)의 최신 뉴스
Why analysts remain bullish on Embecta Corp. stockPortfolio Return Summary & Reliable Price Breakout Signals - mfd.ru
Embecta shareholders back board, pay, and equity plan - TipRanks
Embecta's (NASDAQ:EMBC) Solid Earnings Have Been Accounted For Conservatively - simplywall.st
We Think Embecta's (NASDAQ:EMBC) Solid Earnings Are Understated - Yahoo Finance
embecta names new Chairman of the Board and Lead Independent Director - Sahm
Embecta names CEO Kurdikar as new board chair, picks new lead independent director - Drug Delivery Business
Embecta Corp. Appoints Devdatt Kurdikar as Chairman and Dr. Claire Pomeroy as Lead Independent Director - Quiver Quantitative
embecta CEO Dev Kurdikar adds chair role as Pomeroy becomes lead director - Stock Titan
What’s the RSI of Embecta Corp. stock2025 Trade Ideas & AI Forecasted Entry and Exit Points - mfd.ru
Embecta (NASDAQ:EMBC) Is Paying Out A Dividend Of $0.15 - Yahoo Finance
Can Embecta Corp. stock surprise with earnings upside2025 Stock Rankings & Low Risk High Reward Trade Ideas - mfd.ru
Embecta Announces Board Changes, Effective February 11, 2026 - marketscreener.com
Embecta outlines $1.71B–$1.93B revenue target for 2026 as GLP-1 partnerships gain traction - MSN
Embecta (NASDAQ:EMBC) Trading Down 5%Should You Sell? - MarketBeat
Earnings Beat: Embecta Corp. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models - simplywall.st
Embecta Corp. Just Recorded A 28% EPS Beat: Here's What Analysts Are Forecasting Next - 富途牛牛
Trading the Move, Not the Narrative: (EMBC) Edition - Stock Traders Daily
Embecta (NASDAQ:EMBC) Will Pay A Dividend Of $0.15 - simplywall.st
Embecta Earnings Call: U.S. Headwinds, Global Offsets - TipRanks
3 Healthcare Stocks Paying the Highest Dividends of 2026 - The Motley Fool
Embecta: Stable Execution, GLP-1–Driven Growth Optionality, and Attractive Valuation Support Buy Rating and $25 Target - TipRanks
BTIG Research Reiterates "Buy" Rating for Embecta (NASDAQ:EMBC) - MarketBeat
Embecta Corp. (NASDAQ:EMBC) Q1 2026 Earnings Call Transcript - Insider Monkey
BTIG Reiterates Buy Rating on Embecta (EMBC) with Stable Price T - GuruFocus
Embecta Q1 2026 slides: Beats EPS estimates as international growth offsets U.S. decline By Investing.com - Investing.com South Africa
Embecta (EMBC) Margin Rebound And 4.4x P E Challenge Cautious Narratives - simplywall.st
Embecta Q1 2026 slides: Beats EPS estimates as international growth offsets U.S. decline - Investing.com Nigeria
Embecta Corp. (NASDAQ:EMBC) to Issue $0.15 Quarterly Dividend - MarketBeat
Embecta Q1 Earnings Call Highlights - MarketBeat
Embecta Corp (EMBC) Q1 2026 Earnings Call Highlights: Strategic Progress Amidst Market Challenges By GuruFocus - Investing.com Canada
Embecta reports Q1 adjusted EPS 71c, consensus 67c - TipRanks
Embecta (NASDAQ:EMBC) Releases Earnings Results, Beats Expectations By $0.04 EPS - MarketBeat
Embecta Q1 2026 Earnings Call Transcript - MarketBeat
Embecta Corp. SEC 10-Q Report - TradingView
Revenue Check: What is the PEG ratio of Embecta CorpQuarterly Risk Review & Advanced Swing Trade Entry Alerts - baoquankhu1.vn
Embecta (NASDAQ:EMBC) Shares Gap Up on Better-Than-Expected Earnings - MarketBeat
Embecta stock ticks up on Street-beating Q1 - Drug Delivery Business
Embecta (EMBC) Q1 2026 Earnings Call Transcript - The Globe and Mail
Earnings call transcript: Embecta Q1 2026 beats earnings estimates, stock rises - Investing.com Nigeria
EMBC: Q1 revenue met expectations; U.S. headwinds offset by international growth and GLP-1 progress - TradingView
Embecta (NASDAQ:EMBC) Issues FY 2026 Earnings Guidance - MarketBeat
Embecta earnings beat by $0.04, revenue topped estimates - Investing.com
Embecta Corp (NASDAQ:EMBC) Stock Falls 6.5% on Q1 Revenue Miss Despite EPS Beat - ChartMill
Embecta Corp. Reports First Quarter Fiscal 2026 Financial Results - TradingView
EMBECTA ($EMBC) Releases Q1 2026 Earnings - Quiver Quantitative
Embecta Q1 Earnings Summary & Key Takeaways - Benzinga
embecta Announces Quarterly Cash Dividend - Bluefield Daily Telegraph
Embecta Announces Quarterly Cash Dividend - marketscreener.com
A Look Into Embecta Inc's Price Over Earnings - Benzinga
Yacktman Asset Management LP Has $30.93 Million Stake in Embecta Corp. $EMBC - MarketBeat
Embecta shares tumble 49% after InvestingPro’s overvalued warning By Investing.com - Investing.com India
Embecta Corp (EMBC) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Embecta Corp 주식 (EMBC) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Melcher David F | Director |
Feb 25 '25 |
Buy |
13.67 |
13,000 |
177,646 |
76,681 |
자본화:
|
볼륨(24시간):